TuHURA Biosciences, Inc./NV Quarterly Liabilities and Equity in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
TuHURA Biosciences, Inc./NV quarterly Liabilities and Equity history and growth rate from Q2 2011 to Q3 2024.
  • TuHURA Biosciences, Inc./NV Liabilities and Equity for the quarter ending September 30, 2024 was $4.14M, a 180% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.14M +$2.66M +180% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $6.2M +$2.22M +55.9% Jun 30, 2024 10-Q 2024-11-14
Q1 2024 $7.45M +$706K +10.5% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.89M -$8.03M -81% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $1.48M -$11.7M -88.8% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $3.98M -$12M -75.1% Jun 30, 2023 10-K 2024-10-07
Q1 2023 $6.74M -$6.06M -47.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $9.92M -$7.8M -44% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $13.2M -$9.13M -40.9% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $15.9M +$2.41M +17.8% Jun 30, 2022 10-K 2023-09-18
Q1 2022 $12.8M -$6.06M -32.1% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $17.7M -$2.77M -13.5% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 $22.3M -$788K -3.41% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $13.5M +$10.6M +361% Jun 30, 2021 10-K 2022-09-27
Q1 2021 $18.9M +$13.8M +270% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $20.5M +$14M +215% Dec 31, 2020 10-Q 2021-02-12
Q3 2020 $23.1M +$14.8M +177% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $2.94M -$1.1M -27.2% Jun 30, 2020 10-K 2021-09-28
Q1 2020 $5.1M +$2.65M +108% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $6.51M +$2.47M +61.2% Dec 31, 2019 10-Q 2020-02-13
Q3 2019 $8.36M +$3.61M +76.1% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $4.04M -$3.04M -42.9% Jun 30, 2019 10-K 2020-09-18
Q1 2019 $2.46M -$7.22M -74.6% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $4.04M -$8.18M -66.9% Dec 31, 2018 10-Q 2019-02-11
Q3 2018 $4.75M -$9.7M -67.1% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $7.07M -$836K -10.6% Jun 30, 2018 10-K 2019-09-09
Q1 2018 $9.68M +$7.34M +313% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $12.2M +$8.62M +240% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 $14.4M +$9.4M +186% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $7.91M +$1.56M +24.5% Jun 30, 2017 8-K 2019-06-03
Q1 2017 $2.34M +$1.19M +103% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 $3.59M +$1.41M +64.5% Dec 31, 2016 10-Q 2017-02-10
Q3 2016 $5.05M +$2.02M +66.5% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $6.36M +$3.78M +147% Jun 30, 2016 10-K 2017-09-27
Q1 2016 $1.16M -$2.26M -66.2% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $2.18M -$1.94M -47.1% Dec 31, 2015 10-Q 2016-02-12
Q3 2015 $3.03M -$1.47M -32.6% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 $2.58M -$2.43M -48.5% Jun 30, 2015 10-K 2016-09-13
Q1 2015 $3.41M -$341K -9.08% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 $4.13M -$190K -4.41% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 $4.5M -$896K -16.6% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $5M -$1.52M -23.3% Jun 30, 2014 10-K/A 2015-11-16
Q1 2014 $3.75M -$3.94M -51.2% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $4.32M +$4.14M +2262% Dec 31, 2013 10-KT 2014-08-28
Q3 2013 $5.39M +$5.39M Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $6.52M +$6.52M Jun 30, 2013 10-Q 2013-08-12
Q1 2013 $7.69M +$7.69M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 $183K +$182K Dec 31, 2012 10-KT 2014-08-28
Q3 2012 $609* -$6.23K Sep 30, 2012 10-Q/A 2012-12-20
Q2 2012 $1.79K* -$8.9K Jun 30, 2012 10-Q 2013-01-18
Q1 2012 $2.78K* Mar 31, 2012 10-Q/A 2012-06-05
Q4 2011 $805* Dec 31, 2011 10-Q 2012-02-07
Q3 2011 $6.84K* Sep 30, 2011 10-Q 2011-11-10
Q2 2011 $10.7K Jun 30, 2011 10-K/A 2012-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.